ABOUT STRATEGIES TEAM PORTFOLIO NEWS
ABOUT INNOVATUS LIFE SCIENCES
Innovatus Capital Partners’ Life Sciences strategy (“Innovatus Life Sciences”) seeks to provide growth capital in the form of senior secured debt and equity to support innovative and commercial-stage life science and technology companies. We are long term investors and our goal is to partner with well-known companies that are leaders in their field. We seek to invest $20 to $100 million in public and private commercial-stage companies and offer flexible and creative capital solutions that are tailored to the needs of our business partners to achieve cash flow breakeven and/or a strategic exit.
The investment team has significant industry knowledge and has built a well-known market reputation over the last quarter century. We are passionate about new innovations that address unmet medical needs, improve patient outcomes, reduce healthcare costs and create value for investors. We rely on substantial due diligence to achieve a complete understanding of each investment opportunity that enables us to make investments with conviction.
Innovatus is headquartered in New York City.
Representative Transactions:
